Genital Diseases, Female  >>  nintedanib  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nintedanib / Generic mfg.
LUME-Ovar 1, NCT01015118 / 2008-006831-10: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
3
1366
Europe, Canada, US, RoW
Placebo, Paclitaxel, BIBF 1120, Carboplatin
Boehringer Ingelheim
Ovarian Neoplasms, Peritoneal Neoplasms
04/13
09/16

Download Options